title: [Management of arrhythmia in patients with arterial hypertension].
abstract: We estimated the risk of arrhythmic complications after the use of cardiovascular medications in a prospective study including 123 patients with arterial hypertension and recurrent atrial fibrillation. Dispersion characteristics of P wave and QT interval were studied in patients with left ventricular concentric remodeling, concentric hypertrophy, and eccentric hypertrophy. The role of therapy with beta-blockers. ACE inhibitors, and preductal in the reduction of the risk of atrial fibrillation and ventricular arrhythmia was evaluated.
authors.forename: D V
authors.initials: DV
authors.lastname: Dedov
authors.forename: A P
authors.initials: AP
authors.lastname: Ivanov
authors.forename: I A
authors.initials: IA
authors.lastname: Él'gardt
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy; D019468:Disease Management; D004562:Electrocardiography; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012008:Recurrence; D012306:Risk; D020257:Ventricular Remodeling / Q000187:drug effects / Q000502:physiology
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors